Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 34908 | 59 | 26.2 | 77% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FLUORESCENT FOCUS ASSAY | Author keyword | 1 | 50% | 2% | 1 |
| 2 | FUYOU BRANCH | Address | 1 | 50% | 2% | 1 |
| 3 | GLOBAL NEUROL PROGRAM | Address | 1 | 50% | 2% | 1 |
| 4 | NEW ONSET SEIZURES | Author keyword | 1 | 25% | 3% | 2 |
| 5 | INT NEUROL PSYCHIAT EPIDEMIOL PROGRAM | Address | 1 | 11% | 8% | 5 |
| 6 | CHRONIC MANAGEMENT | Author keyword | 0 | 33% | 2% | 1 |
| 7 | DRUG RESISTENCE | Author keyword | 0 | 33% | 2% | 1 |
| 8 | HIV PSYCHIAT PROGRAM | Address | 0 | 33% | 2% | 1 |
| 9 | MED PHARM ODONTOSTOMATOL BAMAKO | Address | 0 | 33% | 2% | 1 |
| 10 | SAFE TREATMENT | Author keyword | 0 | 33% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FLUORESCENT FOCUS ASSAY | 1 | 50% | 2% | 1 | Search FLUORESCENT+FOCUS+ASSAY | Search FLUORESCENT+FOCUS+ASSAY |
| 2 | NEW ONSET SEIZURES | 1 | 25% | 3% | 2 | Search NEW+ONSET+SEIZURES | Search NEW+ONSET+SEIZURES |
| 3 | CHRONIC MANAGEMENT | 0 | 33% | 2% | 1 | Search CHRONIC+MANAGEMENT | Search CHRONIC+MANAGEMENT |
| 4 | DRUG RESISTENCE | 0 | 33% | 2% | 1 | Search DRUG+RESISTENCE | Search DRUG+RESISTENCE |
| 5 | SAFE TREATMENT | 0 | 33% | 2% | 1 | Search SAFE+TREATMENT | Search SAFE+TREATMENT |
| 6 | PROVOKED SEIZURE | 0 | 20% | 2% | 1 | Search PROVOKED+SEIZURE | Search PROVOKED+SEIZURE |
| 7 | AIDS ENCEPHALOPATHY | 0 | 11% | 2% | 1 | Search AIDS+ENCEPHALOPATHY | Search AIDS+ENCEPHALOPATHY |
| 8 | ANTIELPILEPTIC DRUG | 0 | 100% | 2% | 1 | Search ANTIELPILEPTIC+DRUG | Search ANTIELPILEPTIC+DRUG |
| 9 | ARV RESISTANCE | 0 | 100% | 2% | 1 | Search ARV+RESISTANCE | Search ARV+RESISTANCE |
| 10 | REDOX INTRACELLULAR BALANCE | 0 | 100% | 2% | 1 | Search REDOX+INTRACELLULAR+BALANCE | Search REDOX+INTRACELLULAR+BALANCE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEW ONSET SEIZURES | 3 | 19% | 24% | 14 |
| 2 | AIDS RELATED MANIA | 1 | 50% | 3% | 2 |
| 3 | INDUCED CARBAMAZEPINE TOXICITY | 1 | 25% | 7% | 4 |
| 4 | NONEPILEPTIC CONDITIONS | 0 | 13% | 2% | 1 |
| 5 | MANIC SYNDROMES | 0 | 100% | 2% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Concurrent use of antiretrovirals and anticonvulsants in human immunodeficiency virus (HIV) seropositive patients | 2003 | 15 | 35 | 31% |
| The effect of divalproex sodium on viral load: A retrospective review of HIV-positive patients with manic syndromes | 2001 | 21 | 12 | 25% |
| New-onset seizures in HIV-infected patients - A review and guide to management | 2001 | 1 | 8 | 75% |
| Safe Treatment of Seizures in the Setting of HIV/AIDS | 2013 | 1 | 64 | 17% |
| The use of valproic acid in HIV-positive patients | 1999 | 24 | 19 | 26% |
| HIV infection and seizures | 1999 | 20 | 16 | 25% |
| Antiretroviral therapy and drug interactions | 2001 | 0 | 4 | 25% |
| Epilepsy and Viral Infections | 2014 | 0 | 40 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FUYOU BRANCH | 1 | 50% | 1.7% | 1 |
| 2 | GLOBAL NEUROL PROGRAM | 1 | 50% | 1.7% | 1 |
| 3 | INT NEUROL PSYCHIAT EPIDEMIOL PROGRAM | 1 | 11% | 8.5% | 5 |
| 4 | HIV PSYCHIAT PROGRAM | 0 | 33% | 1.7% | 1 |
| 5 | MED PHARM ODONTOSTOMATOL BAMAKO | 0 | 33% | 1.7% | 1 |
| 6 | CLIN MED NUCL MED | 0 | 25% | 1.7% | 1 |
| 7 | CLIN MED RADIOL | 0 | 25% | 1.7% | 1 |
| 8 | NEUROL INTENS STN | 0 | 25% | 1.7% | 1 |
| 9 | EPILEPSY CARE TEAM | 0 | 11% | 3.4% | 2 |
| 10 | MED LOUISIANA | 0 | 20% | 1.7% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000193375 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |
| 2 | 0.0000179470 | ATAZANAVIR//RITONAVIR//LOPINAVIR |
| 3 | 0.0000166908 | FIRST SEIZURE//SEIZURE RELAPSE//FIRST EPILEPTIC SEIZURE |
| 4 | 0.0000120835 | CARBAMAZEPINE 10 11 EPOXIDE//FREE PHENYTOIN//R 4PK |
| 5 | 0.0000116785 | COMMUNITY RADIO//GRASSROOTS COMMUNITIES//GRASSROOTS COMMUNITY |
| 6 | 0.0000110893 | GENERAL HEALTH PSYCHOLOGIST//CLINICAL PSYCHOLOGIST//PAIDI GRP EPIDEMIOL PSYCHOMETR HLTH BEHAV |
| 7 | 0.0000103247 | HLTH INEQUAL PROGRAM//AIDS CLIN SERV//HLTH INEQUALIT PROGRAM |
| 8 | 0.0000098534 | NEUROAIDS//JOURNAL OF NEUROVIROLOGY//HIV DEMENTIA |
| 9 | 0.0000087144 | ATOVAQUONE//TOXOPLASMIC ENCEPHALITIS//TOXOPLASMA ENCEPHALITIS |
| 10 | 0.0000084856 | INTERNATIONAL GLOBAL IMAGING//RADIOLOGY READINESS//FASH |